Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

In study, individual dogs' performance varied for detecting hypoglycemic episodes, hyperglycemia

Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399

Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years

Higher rates of at least one incident-linked condition seen in men, women with HFE p.C282Y homozygosity

Global adoption of healthy reference diet would reduce morbidity, environmental degradation

IF with 70 percent energy intake has better outcomes versus continuous diet restriction in obese women

Lower risk for diabetes seen for those with normal fasting glucose, not impaired fasting glucose

Closed loop, Open Loop, MDI, Patch Pump. These are all methods of delivering insulin — some so complex, the combination of sensor and pump will manage highs and lows; others so simple, you barely need a meter. However, all of these methods could benefit from CGM devices. This week in our …

Man, 36 years of age, type 2 diabetes, obesity class II, fatty liver, was taking metformin 1,000mg twice daily, and lower dose of SGLT-2. A1C was elevated 9% due to steroids; had been in the 6-7% range. Came in for 3-month follow up — A1C 9.9%, glucose 359, urine positive for glucose and for ketones, gained 19 pounds since last office visit, B/P 126/78-HR 78 and regular. The patient reports he took a "holiday" from everything during the holidays. He ate and drank anything and everything he wanted, including alcohol, and stopped his medications. He complained of  increased hunger and thirst. Very thirsty.